CAPRICOR THERAPEUTICS, INC.CAPR
Market cap
$1.2B
P/E ratio
| Dec 31, 2011 | Dec 31, 2013 | Dec 31, 2014 | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | |
| Cash and cash equivalents | 1 | 2 | 8 | 6 | 3 | 6 | 4 | 4 | 33 | 35 | 10 | 15 | 11 |
| Marketable securities | - | 326,494 | - | 8 | 13 | 8 | 3 | 6 | - | - | 32 | 25 | 140 |
| Receivables | - | - | 360,233 | 211,938 | 223,335 | 344,575 | 204,868 | 87,968 | - | 391,750 | 547,580 | 10 | 10 |
| Prepaid expenses and other current assets | 271,298 | 222,763 | 235,523 | 210,603 | 342,892 | 501,164 | 724,184 | 571,382 | 1 | 1 | 919,892 | 995,776 | 2 |
| TOTAL CURRENT ASSETS | 1 | 4 | 12 | 14 | 18 | 16 | 8 | 11 | 34 | 36 | 43 | 51 | 163 |
| PROPERTY AND EQUIPMENT, net | 9,744 | 74,187 | 229,455 | 318,566 | 435,336 | 372,096 | 574,206 | 442,806 | 850,847 | 2 | 5 | 6 | 6 |
| Lease right-of-use assets, net | - | - | - | - | - | - | - | - | - | 3 | 2 | 2 | 1 |
| Other assets | - | - | - | 70,146 | 61,426 | 95,969 | 151,788 | 119,608 | 88,701 | 275,722 | 268,172 | 268,172 | 221,700 |
| TOTAL ASSETS | 1 | 6 | 14 | 16 | 19 | 16 | 9 | 11 | 35 | 41 | 50 | 59 | 170 |
| Accounts payable and accrued expenses | - | - | 2 | 3 | 3 | 1 | 1 | 875,677 | 3 | 3 | 5 | 6 | 8 |
| Lease liabilities, current | - | - | - | - | - | - | - | - | - | 417,632 | 682,039 | 749,112 | 834,799 |
| Deferred revenue, current | - | - | - | - | - | - | - | - | - | - | 18 | 24 | 12 |
| TOTAL CURRENT LIABILITIES | 541,447 | 2 | 6 | 7 | 5 | 2 | 1 | 897,992 | 3 | 4 | 24 | 31 | 21 |
| CIRM liability | - | - | - | - | - | - | - | - | - | - | - | - | 3 |
| Lease liabilities, net of current | - | - | - | - | - | - | - | - | - | 2 | 2 | 1 | 616,315 |
| TOTAL LONG-TERM LIABILITIES | - | 4 | 14 | 11 | 18 | 3 | 3 | 3 | 3 | 6 | 15 | 5 | 4 |
| TOTAL LIABILITIES | - | 6 | 20 | 17 | 23 | 5 | 5 | 4 | 6 | 10 | 38 | 36 | 25 |
| Preferred Stock, Value, Issued | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Common Stock, Value, Issued | 39,712 | 11,687 | 11,707 | 16,255 | 21,399 | 26,271 | 31,388 | 5,227 | 20,577 | 24,185 | 25,241 | 31,148 | 45,582 |
| Additional paid-in capital | - | - | 16 | 34 | 50 | 63 | 71 | 81 | 116 | 139 | 149 | 182 | 344 |
| Accumulated other comprehensive income | - | -980 | - | 9,385 | 3,524 | 11,620 | 12,393 | -757 | - | - | 105,244 | 235,813 | 1 |
| Accumulated deficit | -44,814,980 | - | -22,315,127 | -35,172,466 | -53,979,242 | -51,547,819 | -66,738,914 | -74,380,731 | -88,037,759 | -108,060,279 | -137,079,811 | -159,367,353 | -200 |
| TOTAL STOCKHOLDERS' EQUITY | 830,723 | -534,882 | -6,248,723 | -1,031,774 | -4,003,154 | 11 | 5 | 7 | 28 | 31 | 12 | 23 | 145 |
| TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY | 1 | 6 | 14 | 16 | 19 | 16 | 9 | 11 | 35 | 41 | 50 | 59 | 170 |